[1] Zhou MG,Wang HD,Zeng XY,et al.Mortality,morbidity,and risk factors in China and its provinces,1990-2017:a systematic analysis for the Global Burden of Disease Study 2017[J].Lancet 2019,394(10204):1145~1158. [2] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国急性缺血性卒中诊治指南2018[J].中华神经科杂志,2018,51(9):666~682. [3] Powers WJ,Rabinstein AA,Ackerson T.et al.Guidelines for the early management of Patients With Acute Ischemic Stroke:2019 Update to the 2018Guidelines for the Early management of acute ischemic stroke:A Guideline for healthcare professionals from the American heart association/americanstrokeassociation.Stroke[J].2019,50(12):e344~418. [4] Demaerschalk BM,Kleindorfer DO,Adeoye OM,et al.Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke:A statement for healthcare professionals from the american heart association/american stroke association[J].Stroke,2016,47:581~641. [5] 《中国脑卒中防治报告》编写组.《中国脑卒中防治报告2019》概要[J].中国脑血管病杂志,2020,17(5):272~281. [6] Chao BH,Yan F,HuaY,etal.Stroke prevention and control system in China:CSPPC-Stroke Program[J] Int J Stroke,2021,16(3):265~272. [7] Li JG,Liu JM,MaYF,etat.Imbalancedregional development of acute ischemic stroke care in emergency departments in China[J].Emerg Med Int,2019,2019:3747910. [8] SauserK,LevineDA,NicklesAV,etal.Hospital variation in thrombolysis times among patients with acute ischemic stroke:the contributions of door-to-imaging time and imaging-to-needle time[J].JAMA Neurol.2014,71(9):1155~1161. [9] Horsch AD,BenninkE,SeetersT,etal.Computedtomography perfusion derived blood-brain barrier permeability does not yet improve prediction of hemorrhagic transformation[J].Cerebrovasc Dis,2018,45(1~2):26~32. [10]WuS,WuB,LiuM,etal.Stroke in China:advances and challenges in epidemiology,prevention,and management[J].Lancet Neurol,2019,18(4):394~405. [11]Kamalian S,Morais LT,Pomerantz SR,et al.Clot length distribution and predictors in anterior circulation stroke:Implications for intra-arterial therapy[J].Stroke,2013,44:3553~3556. [12]Rod r igue s F B,Neves JB,Caldeira D,et al.Endovascular treatment versus medical care alone for ischaemicstroke:Systematic review and metaanalysis[J].BMJ,2016,353:1754. [13]Gregg C F,Xinz,Eric S et al,Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative[J],JAMA,2014,311:1632~1640. [14]《中国卒中中心报告2019》编写组.《中国卒中中心报告2019》概要[J].中国脑血管病杂志,2021,18(5):355~360. |